Bank of America’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-28
| Closed | -$56 | – | 8526 |
|
|
2024
Q3 | $56 | Buy |
28
+5
| +22% | +$10 | ﹤0.01% | 7820 |
|
|
2024
Q2 | $38 | Sell |
23
-12
| -34% | -$31 | ﹤0.01% | 7897 |
|
|
2024
Q1 | $211 | Sell |
35
-57
| -62% | -$373 | ﹤0.01% | 7343 |
|
|
2023
Q4 | $646 | Sell |
92
-8
| -8% | -$62 | ﹤0.01% | 7252 |
|
|
2023
Q3 | $878 | Sell |
100
-35
| -26% | -$328 | ﹤0.01% | 7251 |
|
|
2023
Q2 | $1.59K | Sell |
135
-60
| -31% | -$862 | ﹤0.01% | 7178 |
|
|
2023
Q1 | $3.34K | Buy |
195
+57
| +41% | +$1.24K | ﹤0.01% | 7142 |
|
|
2022
Q4 | $3.64K | Sell |
138
-6
| -4% | -$285 | ﹤0.01% | 7118 |
|
|
2022
Q3 | $15K | Sell |
144
-173
| -55% | -$23.4K | ﹤0.01% | 7133 |
|
|
2022
Q2 | $45K | Buy |
317
+182
| +135% | +$25.4K | ﹤0.01% | 6889 |
|
|
2022
Q1 | $21K | Sell |
135
-2
| -1% | -$323 | ﹤0.01% | 7504 |
|
|
2021
Q4 | $30K | Buy |
137
+67
| +96% | +$13K | ﹤0.01% | 7399 |
|
|
2021
Q3 | $14K | Hold |
70
| – | – | ﹤0.01% | 7496 |
|
|
2021
Q2 | $17K | Sell |
70
-43
| -38% | -$11.8K | ﹤0.01% | 7182 |
|
|
2021
Q1 | $38K | Buy |
113
+78
| +223% | +$31.7K | ﹤0.01% | 6724 |
|
|
2020
Q4 | $13K | Buy |
35
+15
| +75% | +$5.78K | ﹤0.01% | 6676 |
|
|
2020
Q3 | $9K | Sell |
20
-10
| -33% | -$2.82K | ﹤0.01% | 6484 |
|
|
2020
Q2 | $4K | Sell |
30
-10
| -25% | -$1.26K | ﹤0.01% | 6595 |
|
|
2020
Q1 | $4K | Buy |
+40
| New | +$4.76K | ﹤0.01% | 6546 |
|
Other funds holding TFFP
Bank of America's TFFP Position: Q4 2024 in Review
Bank of America sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 28 shares — an estimated $56 sold.
Bank of America first reported a position in TFFP in Q1 2020 and held it in 19 quarters. The position peaked at $45K in Q2 2022. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Bank of America reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Bank of America sold 28 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $56.
- Bank of America first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
- Bank of America's TFF Pharmaceuticals, Inc. Common Stock position peaked at $45K in Q2 2022.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.